CrushSCI.com
133.9Average days
136.5Median days
26Fastest days
367Longest days
4722025 publications

Paper Review Records

All Paper Review Records

30 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

100 days

The CoMPaSS ‐ NMD Atlas Platform: A Secure Multimodal Infrastructure for Harmonized Data Collection, Exploration, and Future Artificial Intelligence–Driven Stratification in Hereditary Neuromuscular Disorders

Authors
R. Corrias; P. Foszner; A. Nuredini; D. Mendelsohn; A. Töpf; J. Díaz‐Manera; M. Obach; A. Garzo; M. Savarese; J. Verdú‐Díaz; S. Pini; G. La Vella; N. Albano; M. Markiel; L. Piorecki; A. Suwalska; M. Socha; M. Marczyk; S. Bonelli; A. DeAngelis; J. Laporte; G. Caudullo; E. Savino; V. Straub; F. M. Santorelli; J. Polanska; M. P. Scipioni; R. Tupler; B. SchoserShow moreShow less
Affiliations
1. FINCONS GROUP AG Lugano Switzerland; 2. Department of Data Science and Engineering Silesian University of Technology Gliwice Poland; 3. Department of Biomedical, Metabolic and Neural Sciences University of Modena and Reggio Emilia Modena Italy; 4. Friedrich‐Baur‐Institute at the Department of Neurology LMU University Hospital, LMU Medizin, Ludwig‐Maximilians‐Universität München Munich Germany; 5. John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute Newcastle University, and Newcastle Upon Tyne Hospitals NHS Foundation Trust Newcastle upon Tyne UK; 6. TECNALIA, Basque Research and Technology Alliance (BRTA) Donostia‐San Sebastián Gipuzkoa Spain; 7. Folkhälsan Research Center Helsinki Finland; 8. Deep Blue S.r.l. Rome Italy; 9. Department of Translational Medicine IGBMC (Institut de Génétique et de Biologie Moléculaire et Cellulaire), Inserm U1258, CNRS UMR7104, University of Strasbourg Illkirch France; 10. CeGaT GmbH Tübingen Germany; 11. Molecular Medicine and Neurogenetics Unit IRCCS Fondazione Stella Maris Pisa ItalyShow moreShow less
Source PDF DOI Publisher page
81 days

Neurofilaments as Biomarkers of Disease Activity and Treatment Response in Spinal Muscular Atrophy

Authors
Sara Petrillo; Giorgia Coratti; Gianpaolo Cicala; Anna Capasso; Maddalena Bianchetti; Adele D′Amico; Michela Catteruccia; Maria Sframeli; Antonio Trabacca; Concetta Palermo; Martina D′Ambrosio; Romina Venditti; Laura Castellini; Martina Malaspina; Emanuela Abiusi; Danilo Tiziano; Stefania Corti; Matteo Garibaldi; Emilio Albamonte; Valeria A. Sansone; Marika Romeo; Sonia Messina; Marika Pane; Giacomo Comi; Enrico Bertini; Fiorella Piemonte; Eugenio MercuriShow moreShow less
Affiliations
1. Muscular and Neurodegenerative Diseases Unit Bambino Gesù Children's Hospital, IRCCS Rome Italy; 2. Pediatric Neurology Unit Catholic University Rome Italy; 3. Centro Clinico Nemo, U.O.C. Neuropsichiatria Infantile Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy; 4. Department of Clinical and Experimental Medicine University of Messina Messina Italy; 5. Unit for Severe Disabilities in Developmental Age and Young Adults (Developmental Neurology and Neurorehabilitation) Scientific Institute IRCCS E. Medea Brindisi Italy; 6. Unit of Medical Genetics, Department of Laboratory Science and Infectious Diseases Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy; 7. Dino Ferrari Centre, Department of Pathophysiology and Transplantation (DEPT) Università degli Studi di Milano Milano Italy; 8. SSD Neuromuscular and Rare Diseases, Department of Neurosciences and Mental Health Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico Milano Italy; 9. Department of Neuroscience, Mental Health and Sensory Organs (NESMOS) Sapienza University of Rome, Sant'Andrea Hospital Rome Italy; 10. The NEMO Center in Milan, Neurorehabilitation Unit University of Milan, ASST Niguarda Hospital Milan ItalyShow moreShow less
Source PDF DOI Publisher page
69 days

Convergence of Cerebrospinal Fluid Neuronal Biomarker Burden and MRI Lesion Pattern and Its Association With Short‐Term Outcome in Neuroinfectious Diseases

Authors
Lucio D'Anna; Deborah K. Erhart; Franz Felix Konen; Christopher M. Weise; Makbule Senel; Caroline Stapf; Dominica Hudasch; Petra Steinacker; Lorenzo Barba; Patrick Oeckl; Jonas Ranke; Nicola Ticozzi; Federico Verde; Steffen Halbgebauer; Thomas Skripuletz; Kurt‐Wolfram Sühs; Hayrettin Tumani; Markus Otto; Samir Abu‐RumeilehShow moreShow less
Affiliations
1. Department of Brain Sciences Imperial College London London England UK; 2. Department of Stroke and Neuroscience Charing Cross Hospital, Imperial College London Healthcare NHS Trust London England UK; 3. Department of Neurology Ulm University Hospital Ulm Germany; 4. Department of Neurology Hannover Medical School Hannover Germany; 5. Department of Neurology Martin‐Luther‐University Halle‐Wittenberg Halle (Saale) Germany; 6. German Center for Neurodegenerative Diseases (DZNE e.V.) Ulm Germany; 7. Department of Neurology and Laboratory of Neuroscience IRCCS Istituto Auxologico Italiano Milan Italy; 8. Department of Pathophysiology and Transplantation, “Dino Ferrari” Center Università Degli Studi di Milano Milan Italy; 9. Cluster of Excellence RESIST (EXC 2155) Hannover Medical School Hannover GermanyShow moreShow less
Source PDF DOI Publisher page
108 days

A Large Multicenter Cohort of Ataxia–Telangiectasia: Clinical, Immunologic, Genetic, and Survival Outcomes

Authors
Saba Fekrvand; Ayda Firouzabadi; Pouya Vakilipour; Dorsa Safari; Samaneh Delavari; Ali Zarezadeh Mehrabadi; Zahra Chavoshzadeh; Hossein Esmaeilzadeh; Samin Sharafian; Farahnaz DorriMoghaddam; Mahnaz Sadeghi‐Shabestari; Fatemeh Tarighat Monfared; Ehsan Khoshnezhad Afkham; Soheila Aleyasin; Farhad Abolnezhadian; Reza Salyanchi; Hamid Ahanchian; Arash Kalantari; Nasrin Behniafard; Tooba Momen; Roya Sherkat; Marzieh Tavakol; Sahar Barzamini; Alireza Shafiei; Taher Cheraghi; Ahmad Vosughimotlagh; Najmeh Sepahi; Peter Olbrich; Isabelle Meyts; Andrew R. Gennery; Hassan Abolhassani; Nima Rezaei; Reza YazdaniShow moreShow less
Affiliations
1. Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Tehran University of Medical Sciences Tehran Iran; 2. Primary Immunodeficiency Diseases Network (PIDNet) Universal Scientific Education and Research Network (USERN) Tehran Iran; 3. Department of Allergy and Clinical Immunology, Mofid Children's Hospital Shahid Beheshti University of Medical Sciences Tehran Iran; 4. Allergy Research Center Shiraz University of Medical Sciences Shiraz Iran; 5. Department of Allergy and Clinical Immunology, Namazi Hospital Shiraz University of Medical Sciences Shiraz Iran; 6. Department of Biology (Molecular and Cellular Biology) Islamic Azad University of Mashhad Mashhad Iran; 7. Department of Immunology and Allergy Tabriz University of Medical Sciences Tabriz Iran; 8. Pediatric Respiratory and Sleep Medicine Research Center, Children's Medical Center Tehran University of Medical Sciences Tehran Iran; 9. Department of Pediatrics, School of Medicine, Children's Medical Center Tehran University of Medical Sciences Tehran Iran; 10. Department of Pediatrics, Abuzar Children's Hospital Ahvaz Jundishapur University of Medical Sciences Ahvaz Iran; 11. Department of Immunology Shahid Beheshti University of Medical Sciences Tehran Iran; 12. Clinical Research Development Unit of Akbar Hospital Mashhad University of Medical Sciences Mashhad Iran; 13. Imam Khomeini Hospital Complex Tehran University of Medical Sciences Tehran Iran; 14. Children Growth Disorder Research Center, Shahid Sadoughi Hospital Shahid Sadoughi University of Medical Sciences Yazd Iran; 15. Department of Allergy and Clinical Immunology Shahid Sadoughi University of Medical Sciences Yazd Iran; 16. Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non‐Communicable Disease Isfahan University of Medical Sciences Isfahan Iran; 17. Immunodeficiecy Diseases Research Center Isfahan University of Medical Sciences Isfahan Iran; 18. Non‐Communicable Diseases Research Center Alborz University of Medical Sciences Karaj Iran; 19. Department of Rheumatology, Mofid Children's Hospital Shahid Beheshti University of Medical Sciences Tehran Iran; 20. Department of Immunology, Bahrami Hospital Tehran University of Medical Sciences Tehran Iran; 21. Department of Pediatrics, 17th Shahrivar Children's Hospital Guilan University of Medical Sciences Rasht Iran; 22. Immunology and Allergy Department, Mofid Children's Hospital Shahid Beheshti University of Medical Sciences Tehran Iran; 23. Pediatrics Infectious Diseases, Rheumatology and Immunology Unit, Institute of Biomedicine of Seville University Hospital Vírgen del Rocío/CSIC/University of Seville Seville Spain; 24. Department of Pharmacology, Pediatrics and Radiology University of Seville Seville Spain; 25. Inborn Errors of Immunity, Department of Microbiology, Immunology and Transplantation KU Leuven Leuven Belgium; 26. Pediatric Immunodeficiency, Department of Pediatrics University Hospitals Leuven Leuven Belgium; 27. Translational and Clinical Research Institute Newcastle University Newcastle upon Tyne UK; 28. Paediatric Stem Cell Transplant Unit Great North Children's Hospital Newcastle upon Tyne UK; 29. Clinic for Pediatric Immunology and Rheumatology, Center for Pediatrics and Adolescent Medicine University Hospital Bonn Bonn GermanyShow moreShow less
Source PDF DOI Publisher page
165 days

Navigating the Challenges of Shared Decision‐Making in Amyloid Immunotherapy for Alzheimer's Disease

Authors
Grâce François; Robin Michalon; Thomas Tannou; Philippe Damier; Sonia Desmoulin; Thibaud LebouvierShow moreShow less
Affiliations
1. Lille Neuroscience & Cognition, UMR‐S 1172, LabEx DISTALZ Université de Lille, Inserm, CHU Lille Lille France; 2. Recherches en éthique et épistémologie, U1018, Espace de Réflexion Éthique de la Région Île‐de‐France Université Paris‐Saclay, CESP, INSERM, Gustave Roussy Villejuif France; 3. Faculté de médecine, Université de Montréal, Centre de Recherche Institut de Gériatrie de Montréal Québec Canada; 4. Nantes Université, INSERM, CHU Nantes, F‐44093 Nantes Hôpital Fondation Rothschild Paris France; 5. Laboratoire Droit et Changement Social, UMR 6297 Nantes Université, CNRS Nantes FranceShow moreShow less
Source PDF DOI Publisher page
137 days

Associations Between the Brain Care Score and Structural Brain Changes and Cognitive Impairment Using Data From the Hamburg City Health Study

Authors
Jenna Schellin; Susanne Sehner; Marie Neumann; Marvin Petersen; Felix Leonard Nägele; Sanjula D. Singh; Jonathan Rosand; Nils Schumacher; Birgit‐Christiane Zyriax; Raphael Twerenbold; Bastian Cheng; Götz Thomalla; Märit JensenShow moreShow less
Affiliations
1. Department of Neurology University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany; 2. Department of Cardiology University Medical Center Hamburg‐Eppendorf (UKE) Hamburg Germany; 3. Brain Care Labs, Department of Neurology, Harvard Medical School Massachusetts General Hospital Boston Massachusetts USA; 4. Broad Institute of MIT and Harvard Cambridge Massachusetts USA; 5. Institute of Human Movement Science, Science and Transfer Center Active City University of Hamburg Hamburg Germany; 6. Research Group Preventive Medicine and Nutrition, Midwifery Science, Health Care Research and Prevention University Medical Center Hamburg‐Eppendorf (UKE) Hamburg GermanyShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does EUROPEAN JOURNAL OF NEUROLOGY take to review a manuscript?

As of 2026-11-17, CrushSCI has 30 complete review records for EUROPEAN JOURNAL OF NEUROLOGY. The fastest paper went from submission to acceptance in 26 days (A Network Meta‐Analysis of Hereditary Transthyretin Amyloidosis With Polyneuropathy Supports a Class Effect, Not a Ranking of Individual Drugs, received 2026-07-03, accepted 2026-07-29); the slowest took 367 days. The average is 133.9 days and the median is 136.5 days.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.